Finance

Lists
Q3 2026 earnings • released • EPS beat +1.25% • Revenue beat +0.61%
See results
ICLR:NASDAQ
ICON PLC
$214.16
+17.04%
(+31.18) 1D
$212.51
-0.77% (-1.65)
After hours
Closed: Oct 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ICLR...
Open
$199.19
High
$214.94
Low
$195.80
Mkt. cap
16.52B
Avg. vol.
963.69K
Volume
0.00
P/E ratio
238.12
52-wk high
$214.94
52-wk low
$66.58
EPS
$0.90
Beta
1.24
Shares outstanding
77.15M
No. of employees
40K
Open
$199.19
High
$214.94
Low
$195.80
Mkt. cap
16.52B
Avg. vol.
963.69K
Volume
0.00
P/E ratio
238.12
52-wk high
$214.94
52-wk low
$66.58
EPS
$0.90
Beta
1.24
Shares outstanding
77.15M
No. of employees
40K
News stories
From web sources and news partners
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress. As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC
CEOBarry Balfe
Employees40.2K
Founded1990
Headquarters-
SectorHealth care
Websiteiconplc.com
Analyst ratings
Based on 11 analysts giving stock ratings to ICLR in the past 3 months
Buy
Buy
6
Hold
5
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ICLR in the last 3 months.
Highest
Current $214.16
$226.00 (+5.53%)
Average
$188.38 (-12.04%)
Lowest
$165.00 (-22.95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Reiterated
$226.00
+5.5%
10/28/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$180.00
-16%
10/28/2026
Luke Sergott
Barclays
Hold
Maintained
$175.00
-18.3%
10/28/2026
Kevin Caliendo
UBS
Hold
Maintained
$195.00
-8.9%
10/20/2026
Lu Li
Bank of America Securities
Hold
Upgraded
-
-
10/09/2026
Michael Ryskin
Bank of America Securities
Hold
Upgraded
-
-
10/09/2026
Patrick B Donnelly
Citi
Hold
Maintained
$175.00
-18.3%
09/18/2026
Albert Hu‏
Citi
Hold
Maintained
$175.00
-18.3%
09/18/2026
Jailendra Singh
Truist Financial
Buy
Reiterated
-
-
09/17/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
$165.00
-23%
08/04/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
$197.00
-8%
08/03/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
$194.00
-9.4%
07/31/2026
‏Brendan Digan‏
Citi
Hold
Maintained
$180.00
-16%
07/31/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
07/29/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$190.00
-11.3%
06/26/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
$188.00
-12.2%
06/25/2026
David Windley
Jefferies
Buy
Reiterated
$193.00
-9.9%
06/25/2026
Sean Dodge
BMO Capital
Buy
Maintained
$187.00
-12.7%
06/25/2026
Max Smock
William Blair
Buy
Reiterated
-
-
06/02/2026
Michael Cherny
Leerink Partners
Hold
Maintained
$145.00
-32.3%
05/28/2026
Jamie Clark
Rothschild & Co Redburn
Hold
Downgraded
$100.00
-53.3%
02/17/2026
Last report
Oct 28, 2026
Fiscal period
Q3 2026
$2.66 / $2.63
+1.25%beat
Revenue / Est. (USD)
2.02B / 2.01B
+0.61%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.04B
2.19B
2.03B
2.06B
Cost of goods sold
1.49B
1.69B
1.55B
1.58B
Cost of revenue
1.49B
1.69B
1.55B
1.58B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
198.75M
-605.04M
202.30M
195.92M
Operating expense
297.24M
850.77M
292.63M
286.68M
Total operating expenses
1.78B
2.54B
1.85B
1.87B
Operating income
258.90M
-355.01M
187.00M
194.21M
Other non operating income
-
-9.38M
-
-
EBT including unusual items
38.10M
-142.45M
127.56M
92.20M
EBT excluding unusual items
210.42M
-409.19M
140.82M
148.58M
Income tax expense
35.75M
-17.01M
22.81M
19.62M
Effective tax rate
93.82%
11.94%
17.88%
21.27%
Other operating expenses
-
1.70B
-
-
Net income
2.36M
-125.44M
104.75M
72.58M
Net profit margin
0.12%
-5.73%
5.15%
3.52%
Earnings per share
3.31
2.52
2.50
2.56
Interest and investment income
1.76M
1.49M
1.82M
3.16M
Interest expense
-50.24M
-46.29M
-48.00M
-48.79M
Net interest expenses
-48.48M
-44.80M
-46.18M
-45.63M
Depreciation and amortization charges
98.50M
-292.17M
90.33M
90.77M
EBITDA
357.40M
-264.19M
277.33M
284.98M
Gain or loss from assets sale
-
-
-
32.95M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps